vs

Side-by-side financial comparison of Montrose Environmental Group, Inc. (MEG) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.

Montrose Environmental Group, Inc. is the larger business by last-quarter revenue ($193.3M vs $158.6M, roughly 1.2× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs -4.3%, a 75.4% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 2.2%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $46.5M).

Montrose Environmental Group, Inc. is an American multinational corporation that provides wide-ranging environmental services. The company is vertically integrated across the environmental industry and supports public and private sector clientele. Montrose is headquartered in Little Rock, Arkansas and incorporated in the U.S. state of Delaware.

Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.

MEG vs STOK — Head-to-Head

Bigger by revenue
MEG
MEG
1.2× larger
MEG
$193.3M
$158.6M
STOK
Growing faster (revenue YoY)
STOK
STOK
+3658.9% gap
STOK
3661.1%
2.2%
MEG
Higher net margin
STOK
STOK
75.4% more per $
STOK
71.2%
-4.3%
MEG
More free cash flow
STOK
STOK
$85.1M more FCF
STOK
$131.7M
$46.5M
MEG

Income Statement — Q4 FY2025 vs Q1 FY2025

Metric
MEG
MEG
STOK
STOK
Revenue
$193.3M
$158.6M
Net Profit
$-8.2M
$112.9M
Gross Margin
38.6%
Operating Margin
-1.3%
70.2%
Net Margin
-4.3%
71.2%
Revenue YoY
2.2%
3661.1%
Net Profit YoY
70.9%
528.0%
EPS (diluted)
$-0.13
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MEG
MEG
STOK
STOK
Q4 25
$193.3M
Q3 25
$224.9M
Q2 25
$234.5M
Q1 25
$177.8M
$158.6M
Q4 24
$189.1M
$22.6M
Q3 24
$178.7M
Q2 24
$173.3M
Q1 24
$155.3M
Net Profit
MEG
MEG
STOK
STOK
Q4 25
$-8.2M
Q3 25
$8.4M
Q2 25
$18.4M
Q1 25
$-19.4M
$112.9M
Q4 24
$-28.2M
$-10.5M
Q3 24
$-10.6M
Q2 24
$-10.2M
Q1 24
$-13.4M
Gross Margin
MEG
MEG
STOK
STOK
Q4 25
38.6%
Q3 25
39.4%
Q2 25
43.4%
Q1 25
39.0%
Q4 24
40.8%
Q3 24
40.9%
Q2 24
39.9%
Q1 24
37.8%
Operating Margin
MEG
MEG
STOK
STOK
Q4 25
-1.3%
Q3 25
4.4%
Q2 25
6.4%
Q1 25
-5.9%
70.2%
Q4 24
-12.1%
-60.4%
Q3 24
-0.6%
Q2 24
-1.5%
Q1 24
-6.5%
Net Margin
MEG
MEG
STOK
STOK
Q4 25
-4.3%
Q3 25
3.7%
Q2 25
7.8%
Q1 25
-10.9%
71.2%
Q4 24
-14.9%
-46.4%
Q3 24
-5.9%
Q2 24
-5.9%
Q1 24
-8.6%
EPS (diluted)
MEG
MEG
STOK
STOK
Q4 25
$-0.13
Q3 25
$0.21
Q2 25
$0.42
Q1 25
$-0.64
$1.90
Q4 24
$-0.91
$-0.15
Q3 24
$-0.39
Q2 24
$-0.39
Q1 24
$-0.53

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MEG
MEG
STOK
STOK
Cash + ST InvestmentsLiquidity on hand
$11.2M
$274.8M
Total DebtLower is stronger
$277.1M
Stockholders' EquityBook value
$451.2M
$350.1M
Total Assets
$981.3M
$406.9M
Debt / EquityLower = less leverage
0.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MEG
MEG
STOK
STOK
Q4 25
$11.2M
Q3 25
$6.7M
Q2 25
$10.5M
Q1 25
$30.3M
$274.8M
Q4 24
$12.9M
$128.0M
Q3 24
$13.0M
Q2 24
$16.9M
Q1 24
$9.5M
Total Debt
MEG
MEG
STOK
STOK
Q4 25
$277.1M
Q3 25
$302.4M
Q2 25
$264.6M
Q1 25
$235.6M
Q4 24
$204.8M
Q3 24
$233.0M
Q2 24
$188.7M
Q1 24
$280.9M
Stockholders' Equity
MEG
MEG
STOK
STOK
Q4 25
$451.2M
Q3 25
$458.7M
Q2 25
$470.3M
Q1 25
$444.1M
$350.1M
Q4 24
$446.3M
$229.0M
Q3 24
$449.2M
Q2 24
$448.8M
Q1 24
$324.5M
Total Assets
MEG
MEG
STOK
STOK
Q4 25
$981.3M
Q3 25
$985.7M
Q2 25
$998.1M
Q1 25
$992.2M
$406.9M
Q4 24
$990.4M
$271.6M
Q3 24
$1.0B
Q2 24
$943.9M
Q1 24
$918.1M
Debt / Equity
MEG
MEG
STOK
STOK
Q4 25
0.61×
Q3 25
0.66×
Q2 25
0.56×
Q1 25
0.53×
Q4 24
0.46×
Q3 24
0.52×
Q2 24
0.42×
Q1 24
0.87×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MEG
MEG
STOK
STOK
Operating Cash FlowLast quarter
$51.9M
$131.8M
Free Cash FlowOCF − Capex
$46.5M
$131.7M
FCF MarginFCF / Revenue
24.1%
83.0%
Capex IntensityCapex / Revenue
2.8%
0.1%
Cash ConversionOCF / Net Profit
1.17×
TTM Free Cash FlowTrailing 4 quarters
$91.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MEG
MEG
STOK
STOK
Q4 25
$51.9M
Q3 25
$28.1M
Q2 25
$21.9M
Q1 25
$5.5M
$131.8M
Q4 24
$32.0M
$-23.2M
Q3 24
$11.4M
Q2 24
$894.0K
Q1 24
$-22.0M
Free Cash Flow
MEG
MEG
STOK
STOK
Q4 25
$46.5M
Q3 25
$22.3M
Q2 25
$19.9M
Q1 25
$2.4M
$131.7M
Q4 24
$29.7M
$-23.2M
Q3 24
$10.2M
Q2 24
$-9.8M
Q1 24
$-29.3M
FCF Margin
MEG
MEG
STOK
STOK
Q4 25
24.1%
Q3 25
9.9%
Q2 25
8.5%
Q1 25
1.3%
83.0%
Q4 24
15.7%
-102.7%
Q3 24
5.7%
Q2 24
-5.6%
Q1 24
-18.9%
Capex Intensity
MEG
MEG
STOK
STOK
Q4 25
2.8%
Q3 25
2.6%
Q2 25
0.8%
Q1 25
1.8%
0.1%
Q4 24
1.2%
0.2%
Q3 24
0.6%
Q2 24
6.1%
Q1 24
4.7%
Cash Conversion
MEG
MEG
STOK
STOK
Q4 25
Q3 25
3.36×
Q2 25
1.19×
Q1 25
1.17×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons